![James E. O'Neill](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
James E. O'Neill
Career history of James E. O'Neill
Former positions of James E. O'Neill
Companies | Position | Start | End |
---|---|---|---|
ANIKA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | - | 2005-05-12 |
Director of Finance/CFO | - | 2005-05-12 | |
Cerulean Pharma, Inc.
![]() Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | Comptroller/Controller/Auditor | - | - |
Corporate Officer/Principal | 2013-12-31 | - |
Training of James E. O'Neill
Massachusetts College of Liberal Arts | Undergraduate Degree |
Statistics
International
United States | 4 |
Operational
Comptroller/Controller/Auditor | 2 |
Director of Finance/CFO | 1 |
Corporate Officer/Principal | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
ANIKA THERAPEUTICS, INC. | Health Technology |
Private companies | 1 |
---|---|
Cerulean Pharma, Inc.
![]() Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Cerulean Pharma, Inc. is a clinical-stage, oncology-focused company, which provides proprietary Dynamic Tumor Targeting Platform to develop differentiated therapies. It specializes in the design and development of nanopharmaceuticals. Cerulean's nanopharmaceuticals are drug-containing nanoparticles designed and optimized to enhance therapeutic agents, ranging from small molecules to therapeutic peptides and RNAi molecules. The company was founded by Alan L. Crane and Ram Sasisekharn on November 28, 2005 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- James E. O'Neill
- Experience